Evidence map›Paper›PMID 41952625›Full record

ArticleHaematologica2026

Clinical and therapeutic impact of newborn screeningbased early detection of ataxia-telangiectasia.

Silvia Ricci, Federica Barbati, Emilia Boccieri, Francesco Quagliarella, Clementina Canessa, Francesca Quaranta, Caterina Pelosi, Lorenzo Lodi, Chiara Azzari, Franco Locatelli

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Silvia RicciDepartment of Health Sciences, University of Florence, Florence, Italy; Immunology Unit, Meyer Children's Hospital IRCCS, Florence.
Federica BarbatiPediatrics and Neonatology Unit, Santo Stefano Hospital, USL Toscana Centro, Prato.
Emilia BoccieriDepartment of Hematology, Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome.
Francesco QuagliarellaDepartment of Hematology, Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome.
Clementina CanessaImmunology Unit, Meyer Children's Hospital IRCCS, Florence.
Francesca QuarantaDepartment of Health Sciences, University of Florence, Florence, Italy; Immunology Unit, Meyer Children's Hospital IRCCS, Florence.
Caterina PelosiDepartment of Health Sciences, University of Florence, Florence, Italy; Immunology Unit, Meyer Children's Hospital IRCCS, Florence.
Lorenzo LodiImmunology Unit, Meyer Children's Hospital IRCCS, Florence, Italy; Department of Neurofarba, University of Florence, Florence. lorenzo.lodi@unifi.it.
Chiara AzzariDepartment of Health Sciences, University of Florence, Florence, Italy; Immunology Unit, Meyer Children's Hospital IRCCS, Florence.
Franco LocatelliDepartment of Hematology, Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy; Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Rome.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41952625
PMCPMC13482224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.